The effect of citrate on euglobulin methods of estimating fibrinolytic activity. 1958

M BUCKELL

UI MeSH Term Description Entries
D002951 Citrates Derivatives of CITRIC ACID.
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012712 Serum Globulins All blood proteins except albumin ( Euglobulin,Euglobulins,Pseudoglobulin,Pseudoglobulins,Serum Globulin,Globulin, Serum,Globulins, Serum
D019343 Citric Acid A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. Citrate,Anhydrous Citric Acid,Citric Acid Monohydrate,Citric Acid, Anhydrous,Uralyt U

Related Publications

M BUCKELL
September 1991, Diabetes research and clinical practice,
M BUCKELL
January 1966, Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie,
M BUCKELL
January 1972, Polskie Archiwum Medycyny Wewnetrznej,
M BUCKELL
November 1952, Archives of biochemistry and biophysics,
M BUCKELL
January 1962, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!